Jeffrey William Henderson
Director, Becton Dickinson.
Companies
- Becton DickinsonBoard member Aug 16, 2018 to now1
- QualcommBoard member Jan 14, 2016 to now2
- Halozyme TherapeuticsBoard member Aug 7, 2015 to now3
- KYNTRA BIO, INC.Board member Aug 13, 2015 to Sep 6, 20234
- Cardinal HealthChief financial officer Apr 19, 2006 to Aug 28, 20145
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Halozyme Therapeutics HALO36,572 shares6$4.5M at $122.96May 5, 2026
Qualcomm QCOM14,599 shares7$2.6M at $176.78Mar 17, 2026
Becton Dickinson BDX9,158 shares8$1.8M at $194.65Jan 29, 2026- KYNTRA BIO, INC. KYNB28,866 shares9$150.7K at $5.22Sep 1, 2023
As of each latest filing. The line shows shares held over time.
Recent filings
- May 5, 2026Granted 3,796 shares of Halozyme Therapeutics6
- Mar 17, 2026Granted 2,563 shares of Qualcomm7
- Mar 8, 2026Returned to company 759 shares at $135.69 of Qualcomm10
- Mar 8, 2026Exercised options 2,355 shares of Qualcomm10
- Jan 27, 2026Granted 1,098 shares of Becton Dickinson8
- May 1, 2025Granted 4,165 shares of Halozyme Therapeutics11
- Apr 28, 2025Sold 200 shares at $61.00 of Halozyme Therapeutics12
- Apr 28, 2025Sold 4,297 shares at $60.34 of Halozyme Therapeutics12
- Apr 1, 2025Sold 503 shares at $64.05 of Halozyme Therapeutics13
- Mar 18, 2025Granted 2,097 shares of Qualcomm14
- Mar 9, 2025Exercised options 1,901 shares of Qualcomm15
- Mar 3, 2025Sold 3,205 shares at $59.12 of Halozyme Therapeutics16
- Mar 3, 2025Sold 1,795 shares at $57.93 of Halozyme Therapeutics16
- Feb 10, 2025Bought 1,500 shares at $233.62 of Becton Dickinson17
- Feb 3, 2025Sold 3,900 shares at $56.41 of Halozyme Therapeutics18
- Feb 3, 2025Sold 1,100 shares at $55.94 of Halozyme Therapeutics18
- Jan 28, 2025Granted 930 shares of Becton Dickinson19
- Jan 6, 2025Sold 10,000 shares at $50.01 of Halozyme Therapeutics20
- Apr 25, 2024Granted 6,501 shares of Halozyme Therapeutics21
- Mar 10, 2024Exercised options 2,056 shares of Qualcomm22
- Jan 23, 2024Granted 900 shares of Becton Dickinson23
- Sep 1, 2023Sold 2,000 shares at $1.03 of KYNTRA BIO, INC.9
- Aug 4, 2023Sold 2,000 shares at $1.91 of KYNTRA BIO, INC.24
- Jul 11, 2023Sold 2,000 shares at $2.69 of KYNTRA BIO, INC.25
- Jun 8, 2023Sold 4,994 shares at $17.69 of KYNTRA BIO, INC.26
Trade performance
| Date | Stock | Trade | Value | Return since | Vs S&P since | Vs S&P, 1 year |
|---|---|---|---|---|---|---|
| Feb 10, 2025 | BDX | Buy | $350.4K | +6.3% | −21.3% | −19.3% |
Returns are price-only (no dividends), measured from the trade date.
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARBecton Dickinson, Board member
- 2SEC EDGARQualcomm, Board member
- 3SEC EDGARHalozyme Therapeutics, Board member
- 4SEC EDGARKYNTRA BIO, INC., Board member
- 5
- 6
- 7
- 8
- 9
- 10SEC EDGARForm 4 filed Mar 9, 2026
- 11SEC EDGARForm 4 filed May 2, 2025
- 12SEC EDGARForm 4 filed Apr 28, 2025
- 13SEC EDGARForm 4 filed Apr 1, 2025
- 14SEC EDGARForm 4 filed Mar 20, 2025
- 15SEC EDGARForm 4 filed Mar 10, 2025
- 16SEC EDGARForm 4 filed Mar 3, 2025
- 17SEC EDGARForm 4 filed Feb 10, 2025
- 18SEC EDGARForm 4 filed Feb 4, 2025
- 19SEC EDGARForm 4 filed Jan 30, 2025
- 20SEC EDGARForm 4 filed Jan 7, 2025
- 21SEC EDGARForm 4 filed Apr 29, 2024
- 22SEC EDGARForm 4 filed Mar 11, 2024
- 23SEC EDGARForm 4 filed Jan 25, 2024
- 24SEC EDGARForm 4 filed Aug 8, 2023
- 25SEC EDGARForm 4 filed Jul 13, 2023
- 26SEC EDGARForm 4 filed Jun 9, 2023